
New randomized trial suggests wearable devices may support resilience and lower burnout odds among physicians.

New randomized trial suggests wearable devices may support resilience and lower burnout odds among physicians.

New platform aims to speed approvals, cut denials and ease physician workload.

Masimo's O3 Regional Oximetry gains FDA clearance, enhancing tissue oxygen monitoring for improved patient care in critical settings.

How medical device manufacturing can be brought back to the US

Cohesys pioneers drill-free fracture repair with BoneTape, offering a patient-friendly alternative for craniofacial injuries and enhancing recovery experiences.

How medical device manufacturing can be brought back to the US

How medical device manufacturing can be brought back to the US

Philips invests over $150 million in U.S. medtech manufacturing, expanding facilities and creating jobs to enhance AI-driven health care solutions.

How medical device manufacturing can be brought back to the US

The acquisitions give StatLab, a developer and manufacturer of medical diagnostic supplies and equipment, a direct foothold in France, Germany, Italy and the United Kingdom.

ArteraAI Prostate advances prostate cancer care with FDA authorization, offering AI-driven insights for personalized treatment and improved diagnostic efficiency.

How medical device manufacturing can be brought back to the US

Cardiosense appoints John Martin as CMO, enhancing AI-driven cardiac care and advancing regulatory efforts for innovative hemodynamic monitoring solutions.

SetPoint Medical secures $140 million to launch innovative neuroimmune modulation therapy for rheumatoid arthritis, advancing treatment for autoimmune diseases.

Discover how Orpyx's innovative sensory insoles advance diabetes foot care, enhancing health outcomes and reducing costs through real-time monitoring and support.

Apreo Health pioneers emphysema treatment with innovative device trials, aiming to transform care for millions suffering from COPD.

Ventric Health advances heart failure detection with the Vivio System, enabling accurate diagnoses in primary care for improved heart health outcomes.

TAO Digital enhances its medtech expertise by acquiring DigitalSoftMinds, boosting capabilities in medical devices and AI-powered solutions for regulated industries.


Yale begins enrolling patients in PRIME study using next-generation Swoop system

Rowan University and NJEDA launch a Strategic Innovation Center to boost medical device investments and accelerate medtech innovation in South Jersey.

Cardiosense's CardioTag gains FDA clearance, advancing cardiac monitoring with wearable technology for personalized, noninvasive heart health insights.

CMS establishes a national payment for AI ECG analysis, paving the way for enhanced cardiovascular diagnostics and early patient intervention.

RenovoRx launches the PanTheR study to evaluate the RenovoCath device's long-term safety and effectiveness in treating solid tumors, advancing cancer care.

Edwards Lifesciences reports robust Q2 growth, raises 2025 guidance, driven by strong TAVR and TMTT sales, enhancing its market leadership.